Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
Conditions
- Osteosarcoma Recurrent
- Osteosarcoma in Children
- Relapsed Osteosarcoma
- Refractory Osteosarcoma
Interventions
- DRUG: Tegavivint
- DRUG: Gemcitabine
Sponsor
Emory University
Collaborators